{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:58:35Z","timestamp":1783547915799,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15363-7","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:56:55Z","timestamp":1765454215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarcopenia measured by artificial intelligence as a predictor of overall survival in localized bladder cancer, a multicenter study"],"prefix":"10.1186","volume":"26","author":[{"given":"Alicia","family":"Blondeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pitout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Manuguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Eschwege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mazeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"15","key":"15363_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.purol.2022.07.145","volume":"32","author":"Y Neuzillet","year":"2022","unstructured":"Neuzillet Y, Audenet F, Loriot Y, Allory Y, Masson-Lecomte A, Leon P, et al. French AFU cancer committee guidelines \u2013 update 2022\u20132024: muscle-invasive bladder cancer (MIBC). Progr\u00e8s En Urologie. 2022;32(15):1141\u201363.","journal-title":"Progr\u00e8s En Urologie"},{"issue":"1","key":"15363_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"issue":"1","key":"15363_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urolonc.2007.07.010","volume":"27","author":"PC Black","year":"2009","unstructured":"Black PC, Brown GA, Dinney CPN. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urologic Oncology: Seminars Original Investigations. 2009;27(1):3\u20137.","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"issue":"2","key":"15363_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.eururo.2020.08.024","volume":"79","author":"C Pfister","year":"2021","unstructured":"Pfister C, Gravis G, Fl\u00e9chon A, Souli\u00e9 M, Guy L, Laguerre B, et al. Randomized phase III trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for patients with Muscle-invasive bladder Cancer. Analysis of the GETUG\/AFU V05 VESPER trial secondary endpoints: chemotherapy toxicity and pathological responses. Eur Urol. 2021;79(2):214\u201321.","journal-title":"Eur Urol"},{"issue":"3","key":"15363_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","volume":"19","author":"JP Stein","year":"2001","unstructured":"Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. JCO. 2001;19(3):666\u201375.","journal-title":"JCO"},{"key":"15363_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2025.08.026","author":"B Ebner","year":"2025","unstructured":"Ebner B, Hirsch J, Holz A, Volz Y, Eismann L, Hermans J, et al. Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma. Urol Oncol. 2025. https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.026.","journal-title":"Urol Oncol"},{"key":"15363_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00345-024-04887-5","volume":"42","author":"N Pyrgidis","year":"2024","unstructured":"Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, et al. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study. World J Urol. 2024;42:164. https:\/\/doi.org\/10.1007\/s00345-024-04887-5.","journal-title":"World J Urol"},{"issue":"8","key":"15363_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1159\/000521829","volume":"106","author":"PL Yannic Volz","year":"2022","unstructured":"Yannic Volz PL, Pfitzinger L, Eismann B, Ebner F, Jokisch GB, Schulz A, et al. Severin Rodler; prognostic value of pretreatment inflammatory markers in patients receiving radical cystectomy for urothelial bladder cancer: does age matter? Urol Int 2 August. 2022;106(8):832\u20139. https:\/\/doi.org\/10.1159\/000521829.","journal-title":"Urol Int 2 August"},{"key":"15363_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00345-025-05876-y","volume":"43","author":"Y Volz","year":"2025","unstructured":"Volz Y, Eismann L, Westhofen T, Pyrgidis N, Pfitzinger PL, Hermans J, et al. Physical activity matters: prognostic impact of preoperative functioning scores in patients undergoing radical cystectomy. World J Urol. 2025;43:512. https:\/\/doi.org\/10.1007\/s00345-025-05876-y.","journal-title":"World J Urol"},{"key":"15363_CR10","unstructured":"Marta Sandini, Manuel Pati\u0148o CR, Ferrone et al. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer | Gastroenterology | JAMA Surg. | JAMA Network. Available from: https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2680073.\u00a0[cited 2024 July 8]"},{"issue":"13","key":"15363_CR11","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","volume":"22","author":"KW Reisinger","year":"2015","unstructured":"Reisinger KW, Bosmans JWAM, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol. 2015;22(13):4445\u201352.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"15363_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jcsm.12107","volume":"7","author":"IJG Rutten","year":"2016","unstructured":"Rutten IJG, van Dijk DPJ, Kruitwagen RFPM, Beets-Tan RGH, Olde Damink SWM, van Gorp T. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016;7(4):458\u201366.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"15363_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clgc.2019.03.007","volume":"13","author":"TD Lyon","year":"2019","unstructured":"Lyon TD, Frank I, Takahashi N, Cheville JC, Viers BR, Tollefson MK. Sarcopenia and response to neoadjuvant chemotherapy for muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;13(3):216\u201322.","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"15363_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcsm.12279","volume":"9","author":"R Mayr","year":"2018","unstructured":"Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, et al. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle. 2018;9(3):505\u201313.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"15363_CR15","unstructured":"Yosuke Hirasawa J, Nakashima D, Yunaiyama T, Sugihara T, Gondo Y, Nakagami Y, et al. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.\u00a0Ann Surg Oncol. Available from: https:\/\/link.springer.com\/article\/10.1245\/s10434-016-5606-4 .\u00a0[cited 2024 July 8]"},{"issue":"3","key":"15363_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.acra.2019.03.011","volume":"27","author":"JE Burns","year":"2020","unstructured":"Burns JE, Yao J, Chalhoub D, Chen JJ, Summers RM. A machine learning algorithm to estimate sarcopenia on abdominal CT. Acad Radiol. 2020;27(3):311\u201320.","journal-title":"Acad Radiol"},{"issue":"8","key":"15363_CR17","doi-asserted-by":"publisher","first-page":"e2328280","DOI":"10.1001\/jamanetworkopen.2023.28280","volume":"6","author":"Z Ye","year":"2023","unstructured":"Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, et al. Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer. JAMA Netw Open. 2023;6(8):e2328280.","journal-title":"JAMA Netw Open"},{"key":"15363_CR18","unstructured":"Blankemeier L, Desai A, Chaves JMZ, Wentland A, Yao S, Reis E et al. Comp2Comp: Open-Source Body Composition Assessment on Computed Tomography. arXiv. 2023. Available from: https:\/\/arxiv.org\/abs\/2302.06568.\u00a0[cited 2024 July 11]"},{"key":"15363_CR19","unstructured":"Martin L, Birdsell L, MacDonald N, Reiman T, Thomas Clandinin M, et al. and Vickie E. Baracos. Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index. Available from:\u00a0https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2012.45.2722?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed.\u00a0[cited 2024 July 8];"},{"key":"15363_CR20","unstructured":"Kenneth Fearon F, Strasser SD, Anker I, Bosaeus E, Bruera RL, Fainsinger A, et al. Definition and classification of cancer cachexia: an international consensus. Available from: https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(10)70218-7\/abstract .\u00a0[cited 2024 July 8];"},{"issue":"7","key":"15363_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"7","key":"15363_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","volume":"26","author":"BJ Caan","year":"2017","unstructured":"Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017;26(7):1008\u201315.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"15363_CR23","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Diagnostic de la d\u00e9nutrition chez l\u2019enfant, l\u2019adulte et la personne de 70 ans et plus \u2013 Fiche outil (Recommandation n\u00b0368). 2021. Haute Autorit\u00e9 de Sant\u00e9. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-11\/reco368_fiche_outil_denutrition_pa_cd_20211110_v1.pdf."},{"issue":"2","key":"15363_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/JU.0000000000004292","volume":"213","author":"V Sharma","year":"2025","unstructured":"Sharma V, et al. Artificial intelligence\u2013based assessment of preoperative muscle and adipose tissue areas from CT images in patients undergoing radical cystectomy. J Urol. 2025;213(2):362\u201370. https:\/\/doi.org\/10.1097\/JU.0000000000004292.","journal-title":"J Urol"},{"key":"15363_CR25","unstructured":"Kalen J, Rimar AP, Glaser S, Kundu EM, Schaeffer J, Meeks et al. Changes in lean muscle mass associated with neoadjuvant platinum-based chemotherapy in patients with muscle invasive bladder cancer. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6218112\/."},{"issue":"6","key":"15363_CR26","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/cancers15061778","volume":"15","author":"SU Engelmann","year":"2023","unstructured":"Engelmann SU, Pickl C, Haas M, Kaelble S, Hartmann V, Firsching M, et al. Body composition of patients undergoing radical cystectomy for bladder cancer: sarcopenia, low psoas muscle index, and myosteatosis are independent risk factors for mortality. Cancers. 2023;15(6):1778.","journal-title":"Cancers"},{"issue":"1","key":"15363_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/bjc.2017.149","volume":"117","author":"M Ebadi","year":"2017","unstructured":"Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117(1):148\u201355.","journal-title":"Br J Cancer"},{"key":"15363_CR28","doi-asserted-by":"crossref","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A et al. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. JNCI: Journal of the National Cancer Institute. 2014;106(6). Available from:\u00a0https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju124.","DOI":"10.1093\/jnci\/dju124"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15363-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:13:58Z","timestamp":1768911238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15363"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15363-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the CNIL (Comit\u00e9 National Informatique et Libert\u00e9, CNIL 2239566 v0) and was conducted following the principles of the Helsinki declaration. Informed consent to participate was obtained from all participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}